- Home
- QLGN vs IDAI Comparison
QLGN vs IDAI Comparison
Compare QLGN & IDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QLGN
- IDAI
- Stock Information
- Founded
- QLGN 1996
- IDAI 2016
- Country
- QLGN United States
- IDAI United States
- Employees
- QLGN N/A
- IDAI N/A
- Industry
- QLGN Biotechnology: Pharmaceutical Preparations
- IDAI Computer Software: Prepackaged Software
- Sector
- QLGN Health Care
- IDAI Technology
- Exchange
- QLGN Nasdaq
- IDAI Nasdaq
- Market Cap
- QLGN 7.4M
- IDAI 7.7M
- IPO Year
- QLGN N/A
- IDAI N/A
- Fundamental
- Price
- QLGN $2.85
- IDAI $4.26
- Analyst Decision
- QLGN
- IDAI Strong Buy
- Analyst Count
- QLGN 0
- IDAI 1
- Target Price
- QLGN N/A
- IDAI $12.00
- AVG Volume (30 Days)
- QLGN 3.4M
- IDAI 260.2K
- Earning Date
- QLGN 11-14-2025
- IDAI 11-07-2025
- Dividend Yield
- QLGN N/A
- IDAI N/A
- EPS Growth
- QLGN N/A
- IDAI N/A
- EPS
- QLGN N/A
- IDAI N/A
- Revenue
- QLGN N/A
- IDAI $3,366,415.00
- Revenue This Year
- QLGN N/A
- IDAI $25.13
- Revenue Next Year
- QLGN N/A
- IDAI $164.45
- P/E Ratio
- QLGN N/A
- IDAI N/A
- Revenue Growth
- QLGN N/A
- IDAI N/A
- 52 Week Low
- QLGN $1.61
- IDAI $1.43
- 52 Week High
- QLGN $8.81
- IDAI $18.75
- Technical
- Relative Strength Index (RSI)
- QLGN 39.72
- IDAI 62.30
- Support Level
- QLGN $2.66
- IDAI $4.13
- Resistance Level
- QLGN $3.36
- IDAI $5.04
- Average True Range (ATR)
- QLGN 0.55
- IDAI 0.44
- MACD
- QLGN -0.17
- IDAI 0.04
- Stochastic Oscillator
- QLGN 5.74
- IDAI 58.67
About QLGN Qualigen Therapeutics Inc.
Qualigen Therapeutics Inc is an early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's program, QN-302, is an investigational small-molecule G-quadruplexes (G4)-selective transcription inhibitor with binding affinity to G4s prevalent in cancer cells.
About IDAI T Stamp Inc.
T Stamp Inc develops and markets identity authentication software solutions for enterprise partners and peer-to-peer markets. The company is engaged in developing proprietary artificial intelligence-powered solutions; researching and leveraging biometric science, cryptography, and data mining to deliver insightful identity & trust predictions while identifying and defending against fraudulent identity attacks, protecting sensitive user information, and extending the reach of digital services through accessibility. The artificial intelligence-powered solutions segment generates revenue principally from software licenses, professional services, and recurring Software-as-a-Service ("SaaS") revenue.